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INTRODUCTION
Staphylococcus aureus is one of the species of the 
genus Staphylococcus. It is a gram positive, non-
motile, catalase positive, coagulase positive, 
SUMMARY
Methicillin-resistant Staphylococcus aureus (MRSA) is a gram-
positive bacterium that is resistant to methicillin and many 
other â-lactam antimicrobials. It was discovered in 1961 in the 
United Kingdom soon after the discovery of methicillin, and 
often referred to in the press a “Superbug”. Since that time, 
MRSA has emerged as a significant problem world wide, and 
the term has evolved to include resistance to additional â-
lactam antimicrobials. Currently, the term MRSA is often used 
to describe multi-drug resistant Staphylococcus aureus. MRSA 
infections occur mostly in hospitals and health care facilities, 
with a higher incidence rate in nursing home or long-term care 
facilities, and transmission is thought to occur primarily from 
colonized or infected persons to other persons. The organism is 
often sub-categorized as Community-acquired MRSA (CA-
MRSA) or hospital-associated MRSA (HA-MRSA). Transmission 
of MRSA was solely from human to animals, with MRSA 
colonization and infection typically occurring with contact 
between the hands of the human and anterior nares (nostrils) 
of the animal. There is now increasing evidence that MRSA can 
be transmitted in both directions, from animal to human 
(zoonotic) and human to animal (reverse zoonotic). MRSA was 
considered only a human pathogen, until a report of MRSA 
mastitis in a dairy cow 'surfaced in 1972. It has now become an 
increasing urgent problem in veterinary medicine, with MRSA 
infections reported in horses, dogs, cats, pet birds, cattle and 
pigs, and recently food products like bovine milk and retailed 
meat. Treatment of the infections involves the use of drugs such 
as vancomycin, teicoplanin, mupuricin, linezolid, clindamycin 
etc, and prevention is mainly by hand hygiene, hand sanitizers 
and the use of protective clothing and devices in the clinics.
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facultative anaerobe, involved in causing a 
number of diseases including boils, pustules, 
impetigo, osteomyelitis, mastitis, septicemia, 
meningitis, pneumonia and toxic shock 
syndrome (Cheesbrough, 2002; Talaro and 
Talaro, 2002). For humans, this organism is an 
important cause of food borne intoxication, 
pneumonia, post operative wound infections, 
and nosocomial bacteremias (Horan et al., 1988; 
Mansouri and Khleghi, 1997). S. aureus is 
considered the most resistant of all non-spore 
forming pathogens, with well developed 
capacities to withstand high salt concentrations 
(7.5 – 10%), extremes in pH and high 
0temperatures (up to 60 C for 60minutes). It also 
remains viable after months of air–drying and 
resists the effects of many disinfectants and 
antibiotics (Talaro and Talaro, 2002). 
S. aureus is known to be notorious in their 
acquisition of resistance to new drugs and 
continues to defy control measures (Talaro and 
Talaro, 2002). Many strains of S. aureus carry a 
wide variety of multi-drug resistant genes on 
plasmids (Ikeagwu et al., 2008). Human isolates 
of S. aureus, unlike animal's isolates, are 
frequently resistant to penicillinase-reistant 
penicillins (Kloos and Bannerman, 1995; 
Tenover and Gaynes, 2005). An organism 
exhibiting this type of resistance is referred to as 
Methicillin (oxacillin)-resistant S. aureus 
(MRSA). Such organisms are also frequently 
resistant to most of the commonly used 
antimicrobial agents, including the amino 
glycosides, macrolides, chloramphenicol, 
tetracycline and fluoroquinolones (Ikeagwu et 
al., 2008). 
Methicillin-resistant Staphylococcus aureus 
(MRSA) is a gram-positive bacterium that is 
resistant to methicillin (a member of the 
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penicillin family) and many other â-lactam 
antimicrobials (â-lactam antimicrobials include 
penicillins and cephalosporins), and are 
resistant to macrolides and aminoglycosides. 
The description “methicillin-resistant” was first 
used in 1961, based on the discovery of a human 
Staphylococcus aureus infection in the United 
Kingdom that was resistant to methicillin 
(Barber, 1961). Since that time, MRSA has 
emerged as a significant problem world wide, 
and the term has evolved to include resistance to 
other â-lactam antimicrobials. Currently, the 
term MRSA is often used to describe multi-drug 
resistant Staphylococcus aureus.    
            
DISCOVERY AND HISTORY OF METHICILLIN 
- RESISTANT STAPHALLOCOCCUS
AUREUS (MRSA)
Methicillin-resistant Staphylococcus aureus was 
discovered in 1961 in the United Kingdom. It 
made its first major appearance in the United 
States in 1981 among intravenous drug users. 
MRSA is often referred to by the press as 
“Superbug” (CDC, 2007). In the past decade or 
so the number of MRSA infections in the United 
States has increased significantly. The Centers 
for Disease Control and Prevention (CDC) 
estimated that the number of MRSA infections in 
hosp i ta l s  doubled  nat ionwide ,  f rom 
approximately 127, 000 in 1999 to 278,000 in 
2005, while annual deaths toll increased from 
11,000 to more than 17,000 (CDC, 2007; Klein et 
al., 2007; Labondeira-ray et al., 2007).  Another 
study by the CDC estimated that MRSA was 
responsible for 94,360  serious infections and 
associated with 18,650 hospital stay-related 
deaths in the United states in 2005 (Klevens et 
al., 2007; CDC, 2007). These figures suggest that 
MRSA infections are responsible for more deaths 
in the US each year than AIDS (Stein, 2007). 
However, there are “associated” deaths, that is, 




Several strains of MRSA have been identified 
based on genetic analysis of the organism. In the 
UK, the most common strains of MRSA are 
EMRSA15 and EMRSA16 (Johnson et al., 2001). 
EMRSA16 has been found to be identical to the 
ST36:USA200, which circulates in the United 
States, and carry the (Staphylococcal Cassette 
Chromosome) SCC<i>mec type II, enterotoxin 
A and toxic shock syndrome toxin I genes (Diep 
et al., 2006). Under new international typing 
system, this strain is now called MRSA252. It is 
not entirely certain why this strain has become so 
successful, whereas previous strains have failed 
to persist. One explanation is the characteristic 
pattern of antibiotic susceptibility exhibited by 
these strains. Both EMRSA15 and EMRSA16 
strains are resistant to erythromycin and 
ciprofloxacin. It is known that S. aureus can 
survive intracellulary (Von Eiff et al., 2001), and 
these strains of S. aureus are therefore able to 
exploit an intracellular niche.
In the United States, most cases of Community-
associated MRSA (CA-MRSA) are caused by a 
Clonal Complex (CC)8 strain designated 
Sequence Type (ST)8:USA300, which carries 
(Staphylococcal Cassette Chromosome) 
SCC<i> mec type IV, Panton-Valentine 
Leukocidin, PSM-alpha and enterotoxin Q and K 
(Diep et al., 2006) and ST1:USA400 (Wang, 
2007). Other community-acquired strains of 
MRSA are ST8:USA500 and ST59:USA1000. In 
many nations of to world, MRSA strains with 
different predominant genetic background types 
have come to predominate among CA-MRSA 
strains; USA300 easily tops the list in the US and 
is becoming more common in Canada. For 
example, in Australia ST93 strains are common, 
while in continental Europe, ST93 strains 
predominate. In Taiwan, ST59 strains, some of 
which are resistant to many non-bete-lactam 
antibiotics, have arisen as common causes of skin 
and soft tissue infections in the community 
(David et al., 2008).
Nomenclature of MRSA strains
MRSA nomenclature varies worldwide, and a 
standard method for typing and naming MRSA 
strains has not yet been adopted; therefore, one 
genetic strain of MRSA may be referred to by 
several different names. The organism is often 
sub-categorized as community-acquired 
(Community-associated) MRSA (CA-MRSA) or 
hospital-associated (Health care-associated) 
MRSA (HA-MRSA) although this distinction is 
complex (Leonard and Markey, 2008).
Community-Associated MRSA (CA-MRSA)
Some have defined CA-MRSA by criteria related 
to the patients suffering from an MRSA infection 
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while other authors have defined CA-MRSA by 
genetic characteristics of the bacteria themselves 
(Okuma I et al., 2002).  CA-MRSA strains were 
first reported in the late 1990s; these cases were 
defined by a lack of exposure to the health care 
setting. In the next several years, it became clear 
that CA-MRSA infections were caused by strains 
of MRSA that differed from the older and better 
studied health care-associated strains (Okuma I 
et al., 2002). CA-MRSA infections occur in 
otherwise healthy people without a recent 
history of hospital ization or cl inical 
presentation, and are usually associated with 
skin and soft tissue infection. Risk factors for CA-
MRSA include crowding, frequent contact, 
compromised skin, contaminated surfaces and 
shared items, and poor hygiene. To date the 
commonest human associated MRSA is USA300 
(Naimi et al., 2003).
Hospital-associated MRSA (HA-MRSA)
HA-MRSA infections occur most commonly in 
immunocompromised individuals in hospitals 
and health care centers. Risk factors for HA-
MRSA include hospitalization, surgery, dialysis, 
long-term care, indwelling devices, and history 
of previous MRSA infection. The bulk of MRSA 
related clinical infections are caused by HA-
MRSA, which are considered “nosocomial”), 
while strains USA 100 are the commonest 
(Hanselman et al., 2006; Klevens et al., 2007). 
RESISTANCE AND VIRULENCE FACTORS
ASSOCIATED WITH MRSA
MRSA has emerged because there are countless 
different strains of a single type, and each has 
subtle natural genetic mutations which make it 
different from another (Weese, 2005).  Some 
strains' genetic makeup accords them a slight 
advantage in fighting off antibiotic attack unlike 
the weaker strains that are eliminated. Strains 
that manage to carry two or three resistance 
genes will have extraordinary powers of 
resistance to antibiotics (Weese, 2005; Voyich et 
al., 2006; Labandeira-ray et al., 2007). 
Resistance is mediated by a gene (mec A) that 
encodes the production of an altered penicillin-
binding protein (PB2a), which does not allow for 
the binding of â-lactams to the bacterial cell wall 
(Weese, 2005). Because â-lactams exert 
antibacterial activity by binding and inhibiting 
enzymes necessary for bacterial cell wall 
synthesis, these antimicrobials are not effective 
against MRSA. 
Novel MRSA isolates that are less likely to be 
resistant to antimicrobial drugs other than â-
lactams have been identified and association 
with epidemic CA-MRSA infections. Such strains 
are commonly susceptible to drugs such as 
clindamycin, gentamycin, tetracycline, and 
rifampin. They are reported to encode the 
virulence genes of the pore-forming, 
bicomponent cytotoxin, Panton-Valentine 
Leukocidin (PVL) (Li-Zhong et al., 2004). 
However, evidence from animal studies has been 
contradictory in assessing the importance of PVL 
in the virulence of these isolates (Voyich et al., 
2006; Labandara-ray et al., 2007). In addition to 
PVL genes, strains that cause CA-MRSA 
infections typically carry Staphylococcal 
chromosomal cassette mec (SCC mec) types IV 
and V which are small genetic resistance 
elements that are presumably mobile (Li-Zhong 
et al., 2004). A single CA-MRSA strain USA 300 
with genetic background corresponding to 
sequence type (ST) 8 by multilocus sequence 
typing (MLST), and defined by pulse-field gel 
electrophoresis has become predominant among 
CA-MRSA isolates in many health centers in the 
United States (Pan et al, 2005; Diep et al., 2006; 
Moran et al., 2006). The reason for the 
dominance of USA300 is unknown.
HUMAN AND ANIMAL CROSS INFECTION
WITH MRSA
For many years, MRSA was considered only a 
human pathogen, until a report of MRSA mastitis 
(udder infection) in a dairy cow surfaced in 1972 
(Devriese et al., 1972). It has now become an 
increasing urgent problem in veterinary 
medicine, with MRSA infections reported in 
horses, dogs, cats, pet birds, cattle and pigs (Lee, 
2003; Baptise et al., 2005; Voss et al., 2005., 
Weese, 2005; 2006; Abbort et al., 2006; Khanna 
et al., 2008; Smith et al., 2009; George et al., 
2010).
It was first thought that the transmission of M 
RSA was solely from human to animals, with 
MRSA colonization and infection typically 
occurring with contact between the hands of the 
human and anterior nares (nostrils) of the 
animal. There is now increasing evidence that 
MRSA can be transmitted in both directions, 
from animal to human (zoonotic) and human to 
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animal (reverse zoonotic). Once exposed to 
MRSA, animals can become colonized, and may 
serve as reservoirs for transmitting the infection 
to other animals and their human handlers 
(Baptise et al., 2005; Klevens et al., 2007; 
Leonard and Markey, 2008; Weese et al., 2006). 
It has been shown that even apparently healthy 
animals may be MRSA reservoirs, and could 
therefore pose a risk to their handlers (Klevens et 
al., 2007, Smith et al., 2009). This has been 
documented in the general community, and is 
becoming increasingly documented in health-
care settings and in animal environments among 
which are veterinary clinics, hospitals, farms, 
and slaughterhouse (Voss and Doebbeling, 1995; 
Lee, 2003; Weese et al., 2006; De Neeling et al., 
2007). Data have indicated that owners and 
veterinary personnel who come into contact with 
MRSA-colonized or MRSA-infected animals may 
become colonized by MRSA (AVMA, 2009).
With human-to-animal transmission of MRSA, 
there is a possibility that until the animal is free 
of infection, re-transmission from the animal to 
man and subsequently human-to-human might 
occur ((Baptise et al., 2005; Voss et al., 2005; 
Leonard and Markey, 2008). In one reported case 
of possible dog-to-human transmission, a 
diabetes mellitus patient and his wife 
experienced recurring MRSA infections and 
difficulty in elimination (decolonization) the 
MRSA. Nares culture of the family dog revealed 
colonization with MRSA, and long-term 
decolonization of the man and his wife were 
feasible after the dog was treated (Manian, 
2003). However, there was no clear evidence 
that the dog was the source of infection. 
There is a concern that antimicrobial treatment 
of MRSA in companion animals may increase 
antimicrobial resistance, and have a subsequent 
effect on the zoonotic transmission or re-
transmission to humans, especially if the humans 
involved are already in an immunocompromised 
state ((Baptise et al., 2005; Klevens et al., 2007).
THE ROLE OF WILD LIFE IN MRSA
INFECTIONS
The first documented case of MRSA transmission 
between zoo animal and its caretakers was 
reported in March, 2009. Strain USA300 was 
isolated from an African elephant calf that was 
being treated for skin pustules; three of its 
caretakers were also colonized. The USA300 
strain, which is the most common type 
associated with human CA-MRSA infections, has 
never been reported as originated from animals. 
The investigation concluded that the calf had 
acquired the MRSA infection from a colonized 
human  ca re take r  ( r eve r se  zoono t i c  
transmission) during the placement of an 
intravenous catheter, and that the calf then 
transmitted the infection to other human 
caretakers (zoonotic transmission) through 
contacts. Although transmission between 
caretakers cannot be ruled out, several factors 
may suggest that transmission occurred from the 
calf to other caretakers (CDC, 2009). 
ZOONOTIC NATURE OF MRSA
Veterinary personnel are at increased risk of 
being MRSA reservoirs and zoonotic 
transmission of MRSA and subsequent MRSA 
colonization should be considered an 
occupational risk for members of the veterinary 
health care team, particularly those in large 
animal practices. At the 2005 American college 
of Veterinary Internal Medicine (ACVIM) forum, 
6.5% of the attending veterinary personnel who 
volunteered to be tested were found to be 
colonized with MRSA. Large animal practitioner 
recorded the highest MRSA colonization with 
15.6%, while small animal practice personnel 
colonization rate was 4.4% (P< 0.001) (AVMA, 
2009).
Farmers are also at risk of being MRSA 
reservoirs. In a survey of pig farmers in the 
Netherlands, 23%  of pig farmers were colonized 
with MRSA, a rate that was 760 times higher 
than the general Dutch population; however, 
only 2 of 40 pigs tested were MRSA positive 
(Huijsden et al., 2006; Wulf et al., 2006). In 
another investigation MRSA strains isolated 
from a pig farmer, his family and farm workers 
were similar to those seen in pigs; however, the 
original source of the MRSA was not established 
(Huijsden et al., 2006). In a comparative study 
human strains of MRSA sequence type (ST) 254 
d i s p l a y e d  m o l e c u l a r - t y p i n g  r e s u l t s  
indistinguishable from those for strains of equine 
origin. Two other equine strains (ST22 and 
ST1117) showed similarity to ST22 human 
strains. The data from this study provide 
evidence that certain MRSA genotypes have 
adapted to more than one mammalian species 
(Walhter et al., 2009).
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PREVALENCE OF MRSA IN ANIMALS 
WITH NON-CLINICAL INFECTIONS
Few data on MRSA colonization rates in non-
clinically affected animals are available. 
Although identification of colonized or infected 
animals is important in the prevention of MRSA, 
the routine screening of all animals is not 
practicable, so there remains the possibility that 
a small percentage of colonized animals will 
remain undetected upon admission to a 
veterinary clinic or hospital (Moris et al., 2006; 
Leonard and Markey, 2008). For instance a 20-
year-old, male, captive, bottlenose dolphin, 
suspected of having pneumonia, was treated 
empirically with ciprofloxacin and co-
trimoxazole. Despite treatment the dolphin died. 
A necropsy culture swab specimen of the anterior 
nares was submitted for bacteriologic 
examination. MRSA was isolated, which was 
shown by pulse-field gel electrophoresis (PFGE) 
to be the Canadian epidemic MRSA (CMRSA) 2 
(USA 100) strain, the predominant hospital- and 
community-associated MRSA found in persons 
in Canada (Oehler et al., 2006).
In a survey conducted in Ireland by Abbott et al. 
(2006), 0.6% prevalence of MRSA colonization 
was detected in non-clinically infected dogs, and 
0.9% prevalence of MRSA colonization was 
detected upon admission to a veterinary clinic. A 
case study by Vitale et al. (2006) described a 3-
year-old neutered male, domesticated cat with a 
history of multifocal patches of crusted and well-
demarcated ulcers on the trunk. MRSA was 
isolated as USA300. Cluny et al. (2009) in a 
study of horses in Vienna Veterinary University 
Hospital between 2006 and 2007 showed that 20 
of 140 horses with suspected wound infections 
were positive of clusters of MRSA strains MRSA 
ST1, ST254 and ST398. Similarly Weese et al. 
(2006) reported colonization rate of MRSA in 
horses admitted to a Veterinary Teaching 
Hospital to be 2.7% admissions.
Studies by Khann et al. (2008) and Smith et al. 
2009) found MRSA colonization rates of 25% 
and 70% in pigs in Europe and U.S. respectively. 
Also in the Netherlands, Wulf and Voss (2008) 
revealed that 39% of the slaughtered pigs were 
positive for an unusual strain of MRSA ST398. 
From poultry flocks, Persoons et al. (2009) 
showed that the number of positive samples 
varied between 1/5 (20%) and 5/5 (100%). 
Strastkova et al. (2009) studied the occurrence 
of MRSA strains in a goat breeding farm. A total 
of 278 samples collected from animals, milk, 
environment and farm personnel between June 
2006 and March 2008 were examined. Eight 
MRSA were detected in the study. Five of them 
originated from goat's milk and three were 
recovered from one human carrier of the farm 
personnel. All obtained MRSA were clonally 
consistent and were characterized as: SCC mec 
types IV, spa type t064, seb positive and for genes 
encoding TSST-1, PVL and exfoliative toxins A 
and B negative.
Similarly, Huber et al. (2010) worked on the 
prevalence of MRSA in humans in contact with 
farm animals, in livestock, and in food animal 
origin in Switzerland. A total of 2,662 samples 
collected from March to September 2009 were 
tested for the presence of MRSA. The collection 
comprised nasal swabs from 148 pig farmers, 
133 veterinarians, 179 slaughtered house 
employees, 800 pigs, 300 calves, 400 cattle, 100 
pooled neck skin swabs from chicken carcasses, 
and 460 food samples of animal origin. 
Moreover, 142 S. aureus strains isolated from 
bovine mastitis milk were included in the study. 
A total of 20 MRSA were detected, derived from 
samples from, 4 (3.0%) of 133 veterinarians, 10 
(1.3%) of 800 pigs, 3 (1.0%) of 300 calves, 1 
(0.3%) of cattle, and 2 (1.4%) of 142 mastitic 
milk samples. In contrast, the MRSA were not 
found in pig farmers, slaughtered house 
employees, poultry, and in food samples such as 
bulk tank milk (BTM), raw milk cheese, and 
minced meats. Genotyping of the MRSA strains 
was performed by multilocus sequence typing, 
spa- and SCC mec-typing, and revealed ST398 
(n=18), ST8 (n=1), ST1 (n=1), spa types t011 
(n=7), t034 (n=11), t064 (n=1), t127 (n=1), 
and SCC mec types IV (n=4) and V (n=16). All 
the 20 MRSA strains were susceptible to 
gentamycin and sulphamethoxazole/-
trimethoprim and all but one were susceptible to 
ciprofloxacin.
Also Cuny et al. (2010) observed that the 
emergence of MRSA in animals such as horses, 
pet animals and productive livestock has raised 
questions of a probable human origin and in 
more general of host specificity of S. aureus. 
Particular clonal lineages are obviously specific 
for humans (e.g. ST15, ST25, and ST45) and 
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other for ruminants (e.g. ST151). MRSA of 
veterinary nosocomial infections (e.g. ST8 and 
ST254 in horses, ST22 in small animals) very 
likely have their origin in health care facilities. 
MRSA ST398 which became first known from 
widespread colonization in industrially raised 
pigs seems to have limited host specificity and is 
able to colonize and to cause infections in 
various hosts. Mechanisms of host adaptation 
and their genomic background are poorly 
understood.
To determine whether Spa type of methicillin-
resistant Staphylococcus aureus (MRSA) in pigs 
belonged to sequence type (ST) 398, 
Guardabassi et al. (2009) analyzed nasal swabs 
from pig carcasses at Hong Kong markets in 
2008. ST9 belonging to spa type t899 was found 
for 16/100 samples, which indicates that a 
distinct lineage has emerged in pigs. In contrast 
to ST398, which has the characteristic of being 
nontypeable by PFGE using Sma I, the 16 MRSA 
were typeable. They displayed 6 PFGE patterns; 
2 predominant types (A1 and B1) were 
associated with SSC mec types IV and V, 
respectively. A search from the scientific 
literature and internet for information about the 
frequency of S. aureus ST9 in humans and 
animals indicated that ST9 is a clone of porcine 
origin (Guardabassi et al., 2009).
PREVALENCE OF MRSA IN FOODS
Transmission of MRSA from animals to humans 
through animal food products has not been 
thoroughly investigated (Lee, 2003; Van Loo et 
al., 2007b), but several factors by may suggest 
that transmission of MRSA through foods is 
possible. For instance, Pu et al. (2008) 
investigated the prevalence of MRSA in 120 
retail meats from 30 grocery stores in Baton 
Rouge, Louisiana. They isolated MRSA from six 
meat samples (5 pork and 1 beef). The MRSA 
strains identified were USA300 and USA100, but 
the investigators did not determined if the 
original source was the meat itself or humans 
who handled the meat prior to purchase. Lee 
(2003) examined the prevalence of MRSA in 
major food animals. Out of the 1,913 specimens 
collected, 28 were MRSA positive, of which 15 
were positive for mec A gene. 17 of the MRSA 
isolated were from milk while pig (meat and 
trachea) and chicken (meat and joint) had 3 and 
8, respectively. Kwon et al. ( 2005) identified the 
staphylococcal cassette chromosome mec ( SCC 
mec) in bovine milk and concluded that MRSA 
isolated from bovine milk harbored a unique SCC 
mec subtype, and they may not be correlated 
with the emergence of CA-MRSA in human 
infection in Korea.
Kitai et al. (2005) investigated the prevalence of 
MRSA in 444 raw meat chicken samples retailed 
at 145 different super markets in 47 prefectures 
through out Japan, between 2002 through 2003. 
S. aureus was isolated from 292 (65.8%) of 444 
and from 131 of 145 different supermarkets. 
Two mec A-positive MRSA strains were isolated 
from raw chicken meat retailed at two 
supermarkets in two prefectures. Kwon et al. 
(2005) in related study showed that fourteen 
MRSA and a silent mec A-carrying methicillin-
susceptible S. aureus (smMSSA) were isolated 
from the milk of cows with an isolation ratio of 
0.18%. SCCmec of the 14 MRSA strains were 
designated as a new subtype IVg, and one 
smMSSA strain was not classified. All the 14 
strains shared panton-Valentine leukocidin 
(PVL) and staphylococcal enterotoxin D (SED), 
SEI and SEJ; the smMSSA strain had only PVL. 
All the MRSA and smMSSA isolates showed no 
multidrug resistance and had community-
acquired MRSA (CA-MRSA) characteristics. 
PFGE revealed that all the isolates except the 
smMSSA belonged to the same genetic lineage, 
and MLST analysis showed that they had no 
genetic relatedness with CA-MRSA which had 
caused human infection in Korea. The study 
concluded that MRSA isolated from bovine milk 
harboured a unique SCCmec subtype, and they 
may not be correlated with the emergence of CA-
MRSA in human infection in Korea.
Also, Tuirkyilmaz et al. (2009) identified MRSA 
strains gathered from 2002 to 2006 from bovine 
milk samples in Aydin region in Turkey. Among 
93 S. aureus isolated from bovine milk with 
mastitis, 16 (17.2%) were resistant to 
methicillin. The MRSA strains were multi-drug 
resistant, with susceptibility rates to 
antimicrobial tested as 0%, 0%, 0%, 0%, 6.25%, 
16.25% and 57.25% for erythromycin, 
clindamycin, chloramphenicol, gentamycin, 
tetracycline, ciprofloxacin and vancomycin 
respectively. Similarly, Virgin et al. (2009) 
estimated the herd prevalence of MRSA among 
US dairy herds by testing bulk tank milk (BTM) 
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samples using genotypic and phenotypic 
methods. 190 MTM samples ere positive for S. 
aureus, out of which 7 were tested positive for 
nuc and mec A, and 2 tested positive for mec A 
only. mec A positive Staphylococcus spp nor MRSA 
was isolated from the remaining 4 samples.
PREVALENCE OF MRSA IN HUMANS
NIGERIA
The epidemiology of MRSA is fast changing and 
has become one of the established pathogen in 
both hospital and community. MRSA infection 
and colonization have been reported in humans 
in Nigeria, in both hospital and outside the 
hospital environment. In Nigeria, several reports 
of human MRSA infections have been 
documented. Ike (2003) observed a prevalence 
rate of 43% at Jos University Teaching Hospital 
while Onanuga et al. (2006a) showed a 
prevalence rate of 76.7% and 68.5% from urine 
samples in Abuja and Zaria respectively among 
health women. The prevalence rate of 20% was 
also recorded in Zaria from non hospital sources 
(Olonitola et al., 2007). Also Taiwo  et al. (2004), 
Fusi Ngwa et al. (2007), and Olowe et al. (2007) 
in separate studies observed a prevalence rate of 
34.7%, 54.9% and 47.8% in Ilorin (University of 
Ilorin Teaching Hospital), Lagos (Pediatric Unit, 
Lagos University Teaching Hospital and Oshogbo 
(Ladoke Akintola University of Technology, 
College oh Health Sciences) respectively.
Ghebremedhin et al. (2009) provided a 
comprehensive overview of the molecular 
epidemiology and genetic diversity of S. aureus 
strains at the largest university clinic in Ibadan, 
Nigeria. From 1,300 patients clinical samples 
collected at the University Teaching Hospital in 
Ibadan, Nigeria, during 1-year surveillance in 
2007, 346 non duplicate S. aureus isolates were 
obtained. All isolates underwent antibiotic 
susceptibility testing, toxin gene analysis, 
multilocus sequence typing, agr group typing, 
and spa typing. For methicillin-resistant S. aureus 
(MRSA), staphylococcal cassette chromosome 
mec (SCC mec) typing was also performed. Of the 
346 isolates, 20.23% were methicillin resistant. 
Thirty-three patients' isolates (47.15%) fulfilled 
the definition criteria for community-associated 
MRSA (CA-MRSA) according to a review of the 
medical charts. The first report of a Panton-
Valentine leukocidin-positive ST88 strain (agr 
III, SCC mec IV) in Nigeria, as well as genetic 
analysis of this strain is present in their study. 
The ST88 strain was resistant to trimethoprim-
sulphamethoxazole as well as to penicillin and 
oxacillin.
Similarly, Okon et al. (2009) in their study 
showed that ninety-six clinical isolates of S. 
aureus from Nigeria were characterized 
phenotypic ally and genetically. Twelve 
multidrug-resistant methicillin-resistant S. 
aureus (MRSA) isolates carrying a new 
staphylococcal cassette chromosome mec 
elements and a high proportion of Panton-
Valentine leukocidin (PVL)-positive methicillin-
susceptible S. aureus (MSSA) isolates was 
observed. The occurrence of multidrug-resistant 
MRSA and PVL positive MSSA isolates entails the 
risk of emergence of a multidrug-resistant PVL-
positive MRSA clone. Also Fadeyi et al. (2010) 
worked on MRSA carriage amongst health 
workers of the critical care units in a Nigeria 
hospital. Of the 198 health worker screened, 104 
had MRSA either in the nose, hand or both giving 
a carriage rate of 52.5%, nasal carriage (38.9%) 
was higher than hand (25.3%). Doctors 
(22.75%) or Nurses (16.7%) were the 
predominant carriers. MRSA isolates were 
resistant to commonly available antibiotics. Only 
1 (1.3%) of the nasal isolates was vancomycin 
resistant. In Kano, Nwanko et al. (2010) studied 
methicillin-resistant S. aureus (MRSA) and their 
antibiotic sensitivity pattern. Their results 
showed that out of the 185 S. aureus tested, 53 
(28.6%) were found to be methicillin resistant. 
While 38 (62%) isolates were obtained from in-
patients 15 (28%) were from out-patients, and 
surgical wound infection had the highest 
prevalence of 32 (60%) isolates.
CLINICAL SIGNS OF MRSA IN ANIMALS
Not all animals who encounter MRSA develop 
clinical signs. While research is ongoing, it 
appears that only a small percentage become ill, 
while most eliminate the organism or become 
colonized without developing clinical signs. 
Among animals, the most commonly reported 
clinical signs are postoperative and wound 
infections, with less reported incidence of 
intravenous catheter site infections, urinary tract 
infections, pneumonia, skin and ear infections; 
skin and ear infections have been most 
commonly reported(Weese, 2005; Vitale et al., 
2006). CA-MRSA strains that cause skin and soft 
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tissues infections (SSTTIs) sometimes contain 
Panton-Valentine Leukocidin exotoxin (PVL). It 
is unclear whether PVL is a relevant virulence 
factor or a marker for some other factor, a toxin 
that produces tissue necrosis (tissue death). CA-
MRSA infection may present as red, swollen, 
painful site with drainage (Vitale et al., 2006; 
Oehler et al., 2009).
DIAGNOSIS OF MRSA
Diagnosis should involve the identification of 
coagulase-positive Staphylococci  to the species 
level, and all S. aureus should then be tested for 
oxacillin resistance, since Methicillin is less 
stable in vitro (Lee, 2003; Ikeh, 2003; 
Hanselman et al., 2006; Onanuga et al., 2006; 
Fusi Ngwa et al., 2007; Olonitola et al., 2007; 
Olowe et al., 2007). Another common laboratory 
test is a rapid latex agglutination test which 
detects the PBP2a protein. PBP2a is a variant 
penicillin binding protein that imparts the ability 
of S. aureus to be resistant to oxacillin (Persoons 
et al., 2009). If there is a recurrent or persistent 
case of skin infection the animal, a small biopsy 
of either the infected skin or a sample of the 
exudates (drainage) from the site may be 
submitted for laboratory diagnosis. A sputum 
culture is recommended for bloodstream and 
urinary infections. If S. aureus is isolated, further 
tests are needed to determine if it is a MRSA 
strain (Seiken, 2009).
MOLECULAR EPIDEMIOLOGY OF MRSA
The most prominent molecular( genetic) typing 
methods are: pulsed field gel electrophoresis( 
PFGE), multilocus sequence typing( MLST), 
Staphylococcal chromosome cassette( SCC) and 
polymerase chain reaction( PCR)( Real-PCR and 
Quantitative-PCR) (Furtalo et al., 2006; , 
Anderson and Weese, 2007; David et al., 2008;  
Francois and Schrenzel, 2008; Denis et al., 
2009). MLST study on the molecular 
epidemiology of MRSA in Alaska revealed that,  
92% of the isolates carried Panton-Valentine 
Leucocidin (PVL) genes ,  a l l  carr ied 
Staphylococcal Chromosomal Cassette mec ( 
SCC mec) type IV, and none belonged to clonal 
complex( CC) 8 (David et al., 2008).  Genotyped 
MRSA isolates by PFGE after digestion of 
chromosomal DNA with sma I,  and MLST gave 
rise to three  PFGE clonal groups ( USA100[ ST5, 
SCC mec type II], USA300[ ST8, SCC  mec type 
IV], and USA500[ ST8, SCC mec type IV] ) 
accounting for 85.2% of all the isolates (Tattevin 
et al., 2009).
Rapid diagnosis of MRSA in animals is still in its 
early stages of development, and to date there is 
a significant delay from collection to acquisition 
of test results for animals, as compared to 
humans (Weese, 2005). Rapid tests that have 
been validated for use in human cases (i.e. real 
time-PCR) do not necessarily perform 
adequately in animal cases, so species-specific 
validation is required (Tattevin et al., 2009). 
There is a new typing method that uses several 
variable number tandem repeat (VNTR) 
sequences for typing animal MRSA isolates, but 
to date there is no published data available 
(Leonard and Markey, 2008).
TREATMENT OF MRSA INFECTIONS 
IN ANIMALS
CA-MRSA has a greater spectrum of 
antimicrobial susceptibility, including sulfa 
drugs, tetracycline, and clindamycin. HA-MRSA 
is resistant even to these antibiotics and often is 
susceptible only to Vancomycin. Vancomycin and 
teicoplanin are glycopeptides antibiotics used to 
treat MRSA infections (Rybak et al., 1991). 
Teicoplanin is a structural congener of 
Vancomycin that has a similar activity spectrum 
but a longer half-life (Rybak et al., 1991). 
Because the oral absorption of Vancomycin and 
teicoplanin is very low, these agents must be 
administered intravenously to control systemic 
infections (Schentag et al., 1998). Treatment of 
MRSA can be complicated, due to its 
inconvenient route of administration. Moreover, 
many clinicians believe that the efficacy of 
Vancomycin against MRSA is inferior to that of 
anti-staphylococcal beta-lactam antibiotics 
against Methicillin-susceptible Staphylococcus 
aureus (MSSA) (Chang et al., 2003; Siegman-
Igara et al., 2005).
Several newly discovered strains of MRSA show 
antibiotic resistance even to Vancomycin and 
teicoplanin. These new evolutions of the MRSA 
bacterium have been dubbed Vancomycin 
intermediate resistant S. aureus (VISA) or 
Vancomycin-resistant S. aureus (VRSA) (Schito, 
2006; Janknet, 1997). Linezolid, quinupristin/ 
dalfopristin, daptomycin, and tetracycline are 
used to treat more severe infections that do not 
respond to glycopeptides such as Vancomycin 
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(Mangkoloratanothai et al., 2003).  MRSA 
infection can be treated with oral agents, 
including lineziod, rifampicin-fusidic acid, 
rifampicin + fluoroquinolone, pristinamycin, co-
trimoxazole (trimethoprim - sulphamethoxa-
zole), doxycycline or minocyline, and 
clindamycin (Birmingham et al., 2003). For 
MRSA mupirocin can potentially eliminate 
MRSA from mucus membrane colonization 
(Furtalo et al., 2006). A new antibiotic called 
platensimycin that had demonstrated successful 
use against MRSA (Wang, 2007). In another 
separate study in University of East London and 
University of York, allicin, a compound in garlic 
and small quantities of silver carbonate was 
found to successfully treat MRSA. There are 
different strains of MRSA, with different degrees 
of immunity to the effects of various antibiotics. 
It does not mean that antibiotics are completely 
powerless against it; it may simply require a 
much higher dose over a much longer period, or 
the use of alternative antibiotics to which the 
bacteria has less resistance. Therefore, if 
antibiotic treatment is necessary, it should be 
guided by the susceptibility of the organism 
(Seiken, 2009).  In a study to of food animals in 
Chonju, Republic of Korea, it was observed that 
all MRSA isolates from the animals ( chicken and 
cattle) were susceptible to amikacin and 
trimethoprim-sulphamethoxazole; all isolates 
from chicken were susceptible to norflacin and 
ofloxacin; and majority of cattle isolate were 
susceptible to tetracycline (Lee, 2003). In 
Belgium all MRSA strains isolated from poultry 
were susceptible to chloramphenical,  
ciprofloxacin, linezolid, mupirocin, quinopristin-
dalfopristin, rifampin, and sulfonamides 
(Furtalo et al., 2006).
CONTROL AND PREVENTION OF MRSA
INFECTIONS IN ANIMALS
As in human medicine, hand hygiene is an 
integral part of the intervention of the spread of 
MRSA between animals and humans. Frequent 
hand washing with soap/detergent and proper 
disinfection of hard surfaces and equipment 
between patients is essential (AVMA, 2009). 
Hand sanitizers should be provided in all 
consulting rooms and kennels to remind staff of 
the need for frequent hand sanitization ((AVMA, 
2009). Uniforms, gloves, disposable aprons and 
masks should be worn when changing dressings 
on infected wounds or to prevent potential 
contact with body fluids or contaminated tissues 
(AVMA, 2009).Eye protection is indicated if 
splashing or aerosols are expected (AVMA, 
2009). All surroundings in the clinic should be 
kept to a high standard of cleanliness. Although 
the cleanliness of floors does not appear to be as 
important as hand-touch sites in the control of 
human MRSA infections, the situation may be 
different in veterinary medicine because many 
animals are examined or treated on the clinic 
floor (AVMA, 2009).
Good hand hygiene by all who encounter the 
animals, both before and after touching the 
animal (AVMA, 2009). When placing an animal 
on a bed, a clean towel or absorbent pad should 
be placed between the pet and the bed linens 
(Leonard et al., 2008).
DISCUSSION
MRSA is now increasingly reported in animals' 
world wide, and new types appear to be evolving 
in animals. These pose a threat to human health 
through occupational exposure and ease of 
spread during the increased movement of 
livestock and contact with veterinary personnel. 
Asymptomatic colonization and shedding of 
MRSA by veterinary personnel couple with the 
unnecessary use of antibiotics may contribute to 
the establishment of MRSA.
The use of antibiotics for treating people and 
animals in most developing countries is 
unregulated such that antibiotics could be 
purchased in pharmacies, general stores, 
markets and even motor parks with the 
implication that there is a widespread and 
uncontrolled abuse. For example patients often 
do not take full course of treatment, and more so 
many antibiotics in the developing countries are 
of low qualities or faked and adulterated coupled 
with bad storage and management processes. All 
these may lead to phenotypic adaptations 
resulting in resistant isolates. MRSA can produce 
a host of conditions ranging from mild to severe 
skin infections to fatal  pneumonias,  
osteomyelitis, septic arthritis, endocarditis, 
abscesses, bacteremias and septicemia.
Based on the numerous studies on MRSA 
worldwide in both humans and animals, there 
are increasing evidences that MRSA as an 
emerging and important zoonotic pathogen. 
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Interspecies transmission (human-to-animal and 
animal-to-man) occurred in many cases (Lee, 
2003). Also, several researchers had 
documented similarities in both phenotypic and 
genotypic characteristics between MRSA strains 
isolated from humans and animals (Khann, et al., 
2008; Dennis et al., 2009; George et al., 
2010).The threat over colonization and infection 
in animals is that they can become carriers or 
reservoirs of MRSA and subsequently may 
transmit the pathogen to humans that are in 
contact with them. Therefore, veterinary 
personnel can acquire MRSA from animals in the 
farms, clinics or hospitals and may spread it to 
humans who are at greater risk of developing 
MRSA infection or to their other patients.
The contamination of food animal products 
(meat, meat and milk products) occurred during 
production, processing and at retail point (Lee, 
2003) and can be a potential  threat to humans 
who handle the foods as well as those consume 
raw or undercooked food (Van Loo et al., 2007).
Despite lack of basic research on the 
epidemiology of MRSA, it is likely that 
overcrowding and close contact between people 
and their animals have played major roles in the 
spread and persistence of MRSA on farms, in 
homes, and in veterinary clinics. Many common 
disease control practices used to protect public 
health may apply equally well to controlling 
MRSA at the animal-human interface. Proper 
hand washing, together with cleaning and 
disinfection of contaminated surfaces, are simple 
and effective mitigation measures that can be 
used to reduce MRSA risk in most situations. 
Depending on the circumstances, additional 
biosecurity measures could include screening of 
animals and animal care staff for MRSA, 
isolation of suspect cases, and strict asepsis 
during surgery (Leonard and Markey, 2008). 
Report on MRSA colonization and infection in 
humans, in both hospital and non hospital 
sources, involving healthy and ill persons have 
been reported and documented in several parts 
of  Nigeria including Lagos, Abuja, Jos, Osogbo, 
Ilorin, Zaria and Kano, but however literature is 
scanty on the prevalence and/or infection in 
animals or veterinary related issues in Nigeria.
CONCLUSSION
The emergence and presence of MRSA in 
humans in Nigeria and other countries of the 
world is both veterinary and public heath 
concern and strongly suggest that there are 
interspecies transmissions, animal-to-animal, 
human-to-animal and animal-to human. The 
epidemiology of MRSA in animals may take 
parallel course to that of the humans, and may 
mean that failure to diagnose and treat MRSA 
conditions in animals can result to recurrent 
MRSA colonization and infections in humans. 
However, information is still scanty on the 
prevalence of MRSA and its association with 
infection in animals in Nigeria. But with the 
emergence of MRSA in animals from other 
countries of the world and also in humans in 
Nigeria, animals in Nigeria may not be an 
exception. Therefore studies are recommended 
to prove this.
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